Cardlytics, Inc. (NASDAQ:CDLX) Shares Sold by Bank of Montreal Can

Bank of Montreal Can lessened its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX) by 54.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,526 shares of the company’s stock after selling 58,930 shares during the quarter. Bank of Montreal Can owned about 0.10% of Cardlytics worth $400,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its position in shares of Cardlytics by 6.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 29,769 shares of the company’s stock worth $432,000 after purchasing an additional 1,774 shares in the last quarter. Canton Hathaway LLC increased its position in shares of Cardlytics by 95.7% in the second quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock valued at $37,000 after buying an additional 2,200 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its stake in shares of Cardlytics by 13.8% during the 1st quarter. Susquehanna Fundamental Investments LLC now owns 31,536 shares of the company’s stock worth $457,000 after buying an additional 3,836 shares during the last quarter. Quest Partners LLC boosted its position in shares of Cardlytics by 160.4% in the 2nd quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock worth $147,000 after buying an additional 11,061 shares in the last quarter. Finally, XTX Topco Ltd acquired a new stake in Cardlytics in the 2nd quarter valued at about $107,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Insider Activity at Cardlytics

In other news, Director Scott A. Hill purchased 40,000 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average cost of $3.58 per share, with a total value of $143,200.00. Following the transaction, the director now owns 40,000 shares in the company, valued at approximately $143,200. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Cardlytics news, Director Scott A. Hill acquired 40,000 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was acquired at an average price of $3.58 per share, with a total value of $143,200.00. Following the transaction, the director now directly owns 40,000 shares in the company, valued at approximately $143,200. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Amit Gupta sold 22,699 shares of the firm’s stock in a transaction dated Wednesday, July 24th. The stock was sold at an average price of $8.66, for a total transaction of $196,573.34. Following the completion of the transaction, the chief operating officer now directly owns 150,569 shares in the company, valued at $1,303,927.54. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,665 shares of company stock valued at $261,149 over the last ninety days. Corporate insiders own 4.40% of the company’s stock.

Cardlytics Stock Performance

Cardlytics stock opened at $3.22 on Friday. The stock’s 50 day moving average price is $3.84 and its 200 day moving average price is $8.12. The firm has a market capitalization of $157.08 million, a PE ratio of -0.73 and a beta of 1.67. Cardlytics, Inc. has a one year low of $2.89 and a one year high of $20.52. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.77 and a current ratio of 1.77.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.12. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The firm had revenue of $69.64 million during the quarter, compared to analyst estimates of $75.39 million. During the same quarter last year, the firm earned ($0.57) EPS. Cardlytics’s quarterly revenue was down 9.2% on a year-over-year basis. As a group, sell-side analysts expect that Cardlytics, Inc. will post -1.72 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on CDLX shares. Northland Securities lowered Cardlytics from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $7.00 to $5.00 in a research note on Friday, August 16th. Lake Street Capital cut Cardlytics from a “buy” rating to a “hold” rating and lowered their price target for the company from $18.00 to $5.00 in a report on Thursday, August 8th. Bank of America lowered shares of Cardlytics from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $4.00 to $3.50 in a report on Thursday, August 15th. Northland Capmk downgraded Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. Finally, Needham & Company LLC cut Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $7.50.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.